Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 607

Related Citations for PubMed (Select 18294743)

1.

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.

Sohn YM, Tandan JB, Yoksan S, Ji M, Ohrr H.

Vaccine. 2008 Mar 20;26(13):1638-43. doi: 10.1016/j.vaccine.2008.01.021. Epub 2008 Feb 4.

PMID:
18294743
2.

Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.

Chotpitayasunondh T, Sohn YM, Yoksan S, Min J, Ohrr H.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S195-203.

PMID:
22043776
3.
4.

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants.

Sohn YM, Park MS, Rho HO, Chandler LJ, Shope RE, Tsai TF.

Vaccine. 1999 May 4;17(18):2259-64.

PMID:
10403593
5.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.

J Infect Dis. 2003 Oct 15;188(8):1213-30. Epub 2003 Oct 3.

6.
7.

Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children.

Xin YY, Ming ZG, Peng GY, Jian A, Min LH.

Am J Trop Med Hyg. 1988 Aug;39(2):214-7.

PMID:
2841880
8.

Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.

Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.

Vaccine. 2008 Oct 16;26(44):5590-4. doi: 10.1016/j.vaccine.2008.07.104. Epub 2008 Aug 30.

PMID:
18761388
9.

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine.

Puthanakit T, Aurpibul L, Yoksan S, Sirisanthana T, Sirisanthana V.

Vaccine. 2010 Aug 16;28(36):5900-2. doi: 10.1016/j.vaccine.2010.06.048. Epub 2010 Jun 29.

PMID:
20600498
10.

Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.

Puthanakit T, Aurpibul L, Yoksan S, Sirisanthana T, Sirisanthana V.

Vaccine. 2007 Nov 28;25(49):8257-61. Epub 2007 Oct 11.

PMID:
17964009
11.

Neutralizing antibody responses to Japanese encephalitis vaccine in children.

Juang RF, Okuno Y, Fukunaga T, Tadano M, Fukai K, Baba K, Tsuda N, Yamada A, Yabuuchi H.

Biken J. 1983 Mar;26(1):25-34.

PMID:
6626137
12.

Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.

Feroldi E, Capeding MR, Boaz M, Gailhardou S, Meric C, Bouckenooghe A.

Hum Vaccin Immunother. 2013 Apr;9(4):889-97. doi: 10.4161/hv.23087. Epub 2013 Feb 26.

13.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
14.

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.

Nasveld PE, Marjason J, Bennett S, Aaskov J, Elliott S, McCarthy K, Kanesa-Thasan N, Feroldi E, Reid M.

Hum Vaccin. 2010 Nov;6(11):906-14. doi: 10.4161/hv.6.11.12854. Epub 2010 Nov 1.

15.

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Erra EO, Askling HH, Rombo L, Riutta J, Vene S, Yoksan S, Lindquist L, Pakkanen SH, Huhtamo E, Vapalahti O, Kantele A.

Clin Infect Dis. 2012 Sep;55(6):825-34. doi: 10.1093/cid/cis542. Epub 2012 Jun 13.

17.

[Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].

Ma FB, Zheng L, Bi C, Tao H, Zhou YL, Zhang JL, Tang FY, Xie P, Zheng CZ, Peng WB, Jiang RJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Feb;24(2):113-5. Chinese.

PMID:
12697111
18.

Neutralizing antibody responses to Japanese encephalitis vaccine in children.

Juang RF, Fukai K.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1983 Sep;16(3):190-7.

PMID:
6680096
19.

Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules.

Tsai TF, Yu YX, Jia LL, Putvatana R, Zhang R, Wang S, Halstead SB.

J Infect Dis. 1998 Jan;177(1):221-3.

20.

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials.

Torresi J, McCarthy K, Feroldi E, Méric C.

Vaccine. 2010 Nov 23;28(50):7993-8000. doi: 10.1016/j.vaccine.2010.09.035. Epub 2010 Oct 8.

PMID:
20934459
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk